跳至主要内容
临床试验/NCT03615339
NCT03615339已完成不适用

The Use of Fermented Whey Concentrate in Healthy Adults

University of Aberdeen1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2015年3月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
1
主要终点
Change in microbiota activity

研究概览

简要总结

Pilot trial: 6-week single arm intervention. Healthy adults (male and female) consume Molkosan (fermented whey) twice a day (AM & PM).

详细描述

Molkosan® is made from fresh organic whey using a special fermentation process involving lactic acid producing bacteria (L+ lactic acid 70g/L). The company, A.Vogel (Roggwil, Switzerland) will provide the product and we will collect biological samples for analysis in a proof of concept study design that will provide preliminary data for future larger studies.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

盲法说明

Unlabelled bottles of treatment

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •age 18-65
  • •BMI 18-40 kg/m-2

排除标准

  • •Severe gastrointestinal disorders,
  • •Kidney disease,
  • •Thromboembolic or coagulation disease,
  • •Hepatic disease,
  • •Alcohol or any other substance abuse
  • •Eating disorders
  • •Unregulated thyroid disease
  • •Dairy intolerance
  • •Antibiotic use within the last 3 months, including prescribed use
  • •Current prebiotic or prebiotic use

研究组 & 干预措施

Molkosan

Experimental

Consumption of Molkosan (fermented whey) 20ml to be diluted in 200ml water prior to use twice a day (morning & evening).

Total duration was 6 weeks.

干预措施: Molkosan (Dietary Supplement)

结局指标

主要结局

Change in microbiota activity

时间窗: Baseline, day 21 and 42

Faecal short-chain fatty acids, measured by gas chromatography

次要结局

  • Change in glucose tolerance (Oral glucose tolerance test (OGTT)(Baseline, day 21 and 42)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验